Search research articles
Contact Us
Filters
Showing results (51-60 of 141) with videos related to
Page
of 15
Sort By:
Marine Pollution Bulletin
|
January 16, 2026
Development and preliminary validation of an analytical methodology for the determination of organic UV filters in zooplankton samples
Eva Íñiguez, Margaux Gouazé, Ana Dinis, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
February 22, 2005
Androgen receptor expression in ductal carcinoma in situ of the breast: not a helpful marker for classification such as estrogen receptor alpha and progesterone receptor
Achim Rody, Raihanatou Diallo, Christopher Poremba, et al.
Fertility and Sterility
|
June 12, 2010
Pregnancy after the calcium ionophore correction of pronuclei position in oocytes after intracytoplasmic sperm injection
Evgenia Isachenko, Vladimir Isachenko, Plamen Todorov, et al.
The American Journal of Pathology
|
June 29, 2010
Polo-like kinase 1 as predictive marker and therapeutic target for radiotherapy in rectal cancer
Franz Rödel, Sarah Keppner, Gianni Capalbo, et al.
Journal of Cancer Research and Clinical Oncology
|
January 7, 2009
Gene expression of ceramide kinase, galactosyl ceramide synthase and ganglioside GD3 synthase is associated with prognosis in breast cancer
Eugen Ruckhäberle, Thomas Karn, Achim Rody, et al.
Supportive Cancer Therapy
|
July 18, 2008
Darbepoetin alfa as primary prophylaxis of anemia in patients with breast cancer treated preoperatively with docetaxel/doxorubicin/cyclophosphamide
Sibylle Loibl, Manfred Kaufmann, Vidya Maataoui, et al.
Journal of Cancer Research and Clinical Oncology
|
June 19, 2008
Prognostic relevance of glucosylceramide synthase (GCS) expression in breast cancer
Eugen Ruckhäberle, Thomas Karn, Lars Hanker, et al.
BMC Cancer
|
December 31, 2008
Targeting cyclin B1 inhibits proliferation and sensitizes breast cancer cells to taxol
Ilija Androic, Andrea Krämer, Ruilan Yan, et al.
The Oncologist
|
March 16, 2012
Capecitabine monotherapy: review of studies in first-line HER-2-negative metastatic breast cancer
Joyce A O'Shaughnessy, Manfred Kaufmann, Friederike Siedentopf, et al.
Cell Cycle (Georgetown, Tex.)
|
January 30, 2009
Long-term downregulation of Polo-like kinase 1 increases the cyclin-dependent kinase inhibitor p21(WAF1/CIP1)
Nina-Naomi Kreis, Katharina Sommer, Mourad Sanhaji, et al.
Page
of 15
Search research articles
Search
Showing results (51-60 of 141) with videos related to
Sort By:
Page
of 15
Marine Pollution Bulletin
|
January 16, 2026
Development and preliminary validation of an analytical methodology for the determination of organic UV filters in zooplankton samples
Eva Íñiguez, Margaux Gouazé, Ana Dinis, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
February 22, 2005
Androgen receptor expression in ductal carcinoma in situ of the breast: not a helpful marker for classification such as estrogen receptor alpha and progesterone receptor
Achim Rody, Raihanatou Diallo, Christopher Poremba, et al.
Fertility and Sterility
|
June 12, 2010
Pregnancy after the calcium ionophore correction of pronuclei position in oocytes after intracytoplasmic sperm injection
Evgenia Isachenko, Vladimir Isachenko, Plamen Todorov, et al.
The American Journal of Pathology
|
June 29, 2010
Polo-like kinase 1 as predictive marker and therapeutic target for radiotherapy in rectal cancer
Franz Rödel, Sarah Keppner, Gianni Capalbo, et al.
Journal of Cancer Research and Clinical Oncology
|
January 7, 2009
Gene expression of ceramide kinase, galactosyl ceramide synthase and ganglioside GD3 synthase is associated with prognosis in breast cancer
Eugen Ruckhäberle, Thomas Karn, Achim Rody, et al.
Supportive Cancer Therapy
|
July 18, 2008
Darbepoetin alfa as primary prophylaxis of anemia in patients with breast cancer treated preoperatively with docetaxel/doxorubicin/cyclophosphamide
Sibylle Loibl, Manfred Kaufmann, Vidya Maataoui, et al.
Journal of Cancer Research and Clinical Oncology
|
June 19, 2008
Prognostic relevance of glucosylceramide synthase (GCS) expression in breast cancer
Eugen Ruckhäberle, Thomas Karn, Lars Hanker, et al.
BMC Cancer
|
December 31, 2008
Targeting cyclin B1 inhibits proliferation and sensitizes breast cancer cells to taxol
Ilija Androic, Andrea Krämer, Ruilan Yan, et al.
The Oncologist
|
March 16, 2012
Capecitabine monotherapy: review of studies in first-line HER-2-negative metastatic breast cancer
Joyce A O'Shaughnessy, Manfred Kaufmann, Friederike Siedentopf, et al.
Cell Cycle (Georgetown, Tex.)
|
January 30, 2009
Long-term downregulation of Polo-like kinase 1 increases the cyclin-dependent kinase inhibitor p21(WAF1/CIP1)
Nina-Naomi Kreis, Katharina Sommer, Mourad Sanhaji, et al.
Page
of 15